Discover our

Services for Media

A person's finger touches a screen.

Are you a media representative looking for content on Bayer? This section provides news, press photos and more.

May 16, 2024
Not intended for UK Media – Late-breaking data from pivotal Phase III studies OASIS 1 and 2 to be presented at 2024 ACOG Annual Meeting:

Elinzanetant significantly reduces frequency and severity of moderate to severe hot flashes associated with menopause

May 16, 2024
Not intended for U.S. and UK Media

Bayer presents latest data from oncology portfolio at 2024 ASCO Annual Meeting

May 15, 2024
Not intended for U.S. and UK Media

Bayer starts Phase I study with novel targeted radionuclide therapy 225Ac-PSMA-Trillium in advanced metastatic prostate cancer


August 06, 2024

Q2 2024 Results / Half-Year Report

November 12, 2024

Q3 2024 Results / Quarterly Statement

March 05, 2025

FY/Q4 2024 Results / Annual Report

April 25, 2025

Annual Stockholders’ Meeting 2025